Australia’s active vaccine safety system

COVID-19 vaccines

Safety data

 

AusVaxSafety is conducting active vaccine safety surveillance of the COVID-19 vaccines in use in Australia to ensure their ongoing safety. The COVID-19 vaccines currently being used are Comirnaty (Pfizer), Vaxzevria (AstraZeneca), Spikevax (Moderna) and Nuvaxovid (Novavax). AusVaxSafety is currently reporting safety data on Pfizer, AstraZeneca, Moderna and Novavax COVID-19 vaccines.

 

AusVaxSafety moving to fortnightly reporting of COVID-19 vaccine safety data

AusVaxSafety has been reporting COVID-19 vaccine safety surveillance data weekly since the vaccination program commenced on 22 February 2021. More than 2.5 million Australians have participated in this surveillance, by completing more than 6.3 million safety surveys, outlining their experience following their COVID-19 vaccination. As a result of this high level of participation, we now have an unprecedented amount of safety data, specific to Australia, on short-term adverse events following vaccination (AEFI). To date, the AEFI data reported are consistent with those seen in clinical trials and surveillance in other countries, reaffirming the safety of COVID-19 vaccines in use in Australia.

The safety data received from the 6.3 million survey responses have remained very stable over this time, with minimal change to the safety profile of the vaccines. As a result, AusVaxSafety will now be updating COVID-19 vaccine safety data on a fortnightly basis, instead of weekly, on this page. The next update will occur on Wednesday 18 May 2022.

The AusVaxSafety team will continue to regularly review data received on an ongoing basis to ensure there are no new safety concerns.

Latest COVID-19 vaccine safety data

Click on the tiles below to view AusVaxSafety COVID-19 vaccine safety data for specific population groups.

Pfizer COVID-19 vaccine adult formulation

View the latest safety data for Pfizer COVID-19 vaccine adult formulation here

Pfizer COVID-19 vaccine paediatric formulation (5-11 years)

View the latest safety data for Pfizer COVID-19 vaccine paediatric formulation (5-11 years) here

Moderna COVID-19 vaccine

View the latest Moderna COVID-19 vaccine safety data here

AstraZeneca COVID-19 vaccine

View the latest AstraZeneca COVID-19 vaccine safety data here

Novavax COVID-19 vaccine

View the latest Novavax COVID-19 vaccine safety data here

Safety data

News & events

All news & events

AusVaxSafety receives funding
from the Australian Government

NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433  |  Fax (612) 9845 1418  |  ABN 53 188 579 090

We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.

Copyright © 2022 AusVaxSafety. All rights reserved

vaccine

Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433  |  Fax (612) 9845 1418  |  ABN 53 188 579 090

Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.